LakeShore Biopharma Co Ltd (LSB)
2.71
-0.39
(-12.58%)
USD |
NASDAQ |
Nov 14, 16:00
2.71
0.00 (0.00%)
After-Hours: 20:00
LakeShore Biopharma Enterprise Value
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 98.18M |
| November 12, 2024 | 99.33M |
| November 11, 2024 | 85.21M |
| November 08, 2024 | 77.23M |
| November 07, 2024 | 82.92M |
| November 06, 2024 | 80.44M |
| November 05, 2024 | 80.06M |
| November 04, 2024 | 81.97M |
| November 01, 2024 | 80.25M |
| October 31, 2024 | 83.49M |
| October 30, 2024 | 88.26M |
| October 29, 2024 | 90.36M |
| October 28, 2024 | 96.49M |
| October 25, 2024 | 98.74M |
| October 24, 2024 | 98.95M |
| October 23, 2024 | 99.33M |
| October 22, 2024 | 87.69M |
| October 21, 2024 | 94.37M |
| October 18, 2024 | 99.14M |
| October 17, 2024 | 102.96M |
| October 16, 2024 | 109.63M |
| October 15, 2024 | 111.16M |
| October 14, 2024 | 111.35M |
| October 11, 2024 | 110.97M |
| October 10, 2024 | 111.73M |
| Date | Value |
|---|---|
| October 09, 2024 | 113.64M |
| October 08, 2024 | 115.55M |
| October 07, 2024 | 102.19M |
| October 04, 2024 | 143.02M |
| October 03, 2024 | 169.17M |
| October 02, 2024 | 169.17M |
| October 01, 2024 | 169.17M |
| September 30, 2024 | 169.17M |
| September 27, 2024 | 198.80M |
| September 26, 2024 | 187.52M |
| September 25, 2024 | 185.96M |
| September 24, 2024 | 185.48M |
| September 23, 2024 | 186.15M |
| September 20, 2024 | 185.96M |
| September 19, 2024 | 181.19M |
| September 18, 2024 | 186.38M |
| September 17, 2024 | 189.98M |
| September 16, 2024 | 176.23M |
| September 13, 2024 | 153.33M |
| September 12, 2024 | 138.46M |
| September 11, 2024 | 142.95M |
| September 10, 2024 | 126.23M |
| September 09, 2024 | 124.90M |
| September 06, 2024 | 123.37M |
| September 05, 2024 | 123.39M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
73.47M
Minimum
Feb 02 2024
965.65M
Maximum
Mar 17 2023
152.02M
Average
149.15M
Median
Enterprise Value Benchmarks
| Sinovac Biotech Ltd | -6.942B |
| CASI Pharmaceuticals Inc | 91.55M |
| Zai Lab Ltd | 2.423B |
| China SXT Pharmaceuticals Inc | -8.059M |
| Adagene Inc | 29.78M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -14.51M |
| Revenue (Quarterly) | 13.38M |
| Total Expenses (Quarterly) | 27.21M |
| EPS Diluted (Quarterly) | -0.1565 |